- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
APRIL 8, 1998 (APRIL 3, 1998)
Date of Report (Date of earliest event reported)
BECTON, DICKINSON AND COMPANY
(Exact Name of Registrant as Specified in Charter)
NEW JERSEY 1-4802 22-0760120
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
1 BECTON DRIVE
FRANKLIN LAKES, NEW JERSEY 07417-1880
(Address of Principal Executive Offices) (Zip Code)
(201) 847-6800
(Registrant's telephone number, including area code)
- --------------------------------------------------------------------------------
<PAGE>
ITEM 5. OTHER EVENTS.
On April 3, 1998, Becton, Dickinson and Company (the
"Company") announced in a press release that it had consummated the acquisition
of the Medical Devices Division of Ohmeda, the health care business of The BOC
Group, Inc. Attached hereto as Exhibit 99, which is hereby incorporated herein
by reference, is a copy of such press release. The purchase price was
approximately $452 million dollars in cash, subject to adjustment.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits
Exhibit 99 Becton, Dickinson and Company Press Release issued on
April 3, 1998.
-2-
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
BECTON DICKINSON AND COMPANY
By: /s/ Bridget M. Healy
Name: Bridget M. Healy
Title: Vice President, Secretary, and
Associate General Counsel
Date: April 8, 1998
-3-
<PAGE>
INDEX TO EXHIBITS
EXHIBIT
NUMBER DESCRIPTION
99 Becton, Dickinson and Company Press Release issued on
April 3, 1998.
-4-
EXHIBIT 99
Release Date: April 3, 1998
BECTON DICKINSON COMPLETES ACQUISITION OF
MEDICAL DEVICES DIVISION OF THE BOC GROUP
FRANKLIN LAKES, NJ - (APRIL 3, 1998) --Becton Dickinson and
Company (NYSE:BDX.N) announced today that it has completed its acquisition of
Ohmeda's Medical Devices Division from The BOC Group. The purchase price for the
transaction was $452 million dollars. The acquisition will be part of Becton
Dickinson's worldwide infusion therapy business.
CONTACT: Becton Dickinson and Company, Franklin Lakes
R. Jasper, 201/847-7160
-5-
